Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/13/1994 | CA2158171A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
10/13/1994 | CA2158056A1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof |
10/13/1994 | CA2157766A1 Analogs of peptide yy and uses thereof |
10/13/1994 | CA2156641A1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use |
10/13/1994 | CA2156620A1 Chelating agents of the type xn1s1o for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy |
10/13/1994 | CA2156619A1 Chelators agents of the type xn1s1x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses |
10/13/1994 | CA2156618A1 Bifunctional chelators and their use in radiopharmaceuticals |
10/13/1994 | CA2136973A1 Recombinant timothy grass pollen allergen ph1 pii |
10/12/1994 | EP0619372A1 Tumor necrosis factor muteins |
10/12/1994 | EP0619371A1 Polypeptide derived from a glioblastoma cell line, its use and DNAs encoding it |
10/12/1994 | EP0619370A1 Keratinocyte growth factor (KGF) for its use in method of therapeutic treatment for the human or animal body |
10/12/1994 | EP0619322A2 Prolonged delivery of peptides |
10/12/1994 | EP0619321A1 Very large scale immobilized peptide synthesis |
10/12/1994 | EP0619118A1 Use of peptide derivatives |
10/12/1994 | EP0618976A1 Synthetic dna sequence having enhanced insecticidal activity in maize |
10/12/1994 | EP0618975A1 Dna, dna constructs, cells and plants derived therefrom |
10/12/1994 | EP0618972A1 CONSTITUTIVE EXPRESSION OF P450SOY AND FERREDOXIN-SOY IN $i(STREPTOMYCES), AND BIOTRANSFORMATION OF CHEMICALS BY RECOMBINANT ORGANISMS |
10/12/1994 | EP0618971A1 Method for refolding igf-i to active conformation |
10/12/1994 | EP0618970A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
10/12/1994 | EP0618968A1 Tools for the diagnosis and treatment of alzheimer's disease |
10/12/1994 | EP0618967A1 Ifn-gamma antagonist cytokine |
10/12/1994 | EP0618965A1 Method for generating structural and functional diversity in a peptide sequence |
10/12/1994 | EP0618930A1 Monoclonal antibody to hiv-2 and uses thereof |
10/12/1994 | EP0618929A1 Bispecific antibody heterodimers |
10/12/1994 | EP0618927A1 Cytokines with an unpaired cysteine residue and conjugates thereof |
10/12/1994 | EP0618926A1 New peptide derivatives |
10/12/1994 | EP0618925A1 Gapped 2' modified oligonucleotides |
10/12/1994 | EP0618923A1 Peptide nucleic acids and their effect on genetic material |
10/12/1994 | EP0618814A1 Recombinant bovine herpesvirus type 1 polypeptides and vaccines |
10/12/1994 | EP0618813A1 Antigen of hybrid m protein and carrier for group a streptococcal vaccine |
10/12/1994 | EP0618812A1 Use of protease nexin-i as an antiinflammatory |
10/12/1994 | EP0618811A1 Proteolytic mixture containing escharase and method of isolating same |
10/12/1994 | EP0618807A1 A stabilized pharmaceutical formulation comprising growth hormone and histidine |
10/12/1994 | EP0618804A1 Peptides corresponding to antigenic determinants of htlv |
10/12/1994 | EP0618803A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
10/12/1994 | EP0618802A1 Synthetic compounds and compositions with enhanced cell binding |
10/12/1994 | EP0555336A4 Homobifunctional agents for coupling enzymes and the like to antibodies and the like. |
10/12/1994 | EP0546099B1 Use of human Interferon gamma 4-134 |
10/12/1994 | EP0494294B1 Bacterial stress proteins |
10/12/1994 | EP0487619B1 Von casein-beta ausgehendes verfahren zur herstellung von fraktionen, die mit biologisch aktiven peptiden angereichert sind sowie die so erhaltenen peptidfraktionen |
10/12/1994 | EP0471011B1 HUMAN LACTOFERRIN cDNA SEQUENCE |
10/12/1994 | EP0434713B1 Hiv-1 envelope muteins lacking hypervariable domains |
10/12/1994 | CN1093406A Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 |
10/11/1994 | US5354900 Diuretics, hypotensive agents |
10/11/1994 | US5354848 Producing simple or substituted carbamylic amino groups, or substituted thiocarbamylic amino groups or substituted guanidino groups; hyposensitizing therapy |
10/11/1994 | US5354847 Chimeric antibody with specificity to human tumor antigen |
10/11/1994 | US5354846 Streptolysin O antigen derivatives, its production and uses |
10/11/1994 | US5354845 FK-506 and rapamycin specific binding immunophilin |
10/11/1994 | US5354843 Bone disorders; antiarthritic agents; medical diagnosis of thyroid cancer; automatic solid phase synthesis; resin peptides |
10/11/1994 | US5354765 Synergistic |
10/11/1994 | US5354738 Amino acid derivatives |
10/11/1994 | US5354736 Synthetic compounds and compositions with enhanced cell binding |
10/11/1994 | US5354691 Immunogens inducing resistance to autoimmune arthritis |
10/11/1994 | US5354690 Immunological methods for the detection of the human type IV collagen α5 chain |
10/11/1994 | US5354684 Agrobacterium radiobacter K84 carrying transfer-deficient pAgK84 plasmids |
10/11/1994 | US5354678 Production of recombinant adeno-associated virus vectors |
10/11/1994 | US5354666 Mammalian cell line expressing basement membrane proteins |
10/11/1994 | US5354665 Recombinant DNA processes for producing PI-linked lymphocyte function associated antigen-3 |
10/11/1994 | US5354664 Anticoagulants |
10/11/1994 | US5354661 Monoclonal antibody to enterohemorrhagic Escherichia coli 0157:H7 and 026:H11 and method for detection |
10/11/1994 | US5354557 Unglycosylated polypeptide chains having disulfide bonding; peridontal or dental reconstruction, inducing bone formation |
10/11/1994 | US5354555 Against Infectious Hematopoietic Necrosis virus |
10/11/1994 | US5354269 Method for treating cancer resections |
10/11/1994 | CA1332367C Method for the reduction of heterogeneity of monoclonal antibodies |
10/11/1994 | CA1332366C Leukotoxin gene of pasteurella haemolytica |
10/11/1994 | CA1332354C Pharmaceutical formulation for the treatment of diabetes mellitus |
10/07/1994 | CA2120693A1 Polypeptide and dnas encoding it |
10/06/1994 | DE4339922C1 Vector for gene therapy of the liver |
10/06/1994 | DE4310643A1 Cyclic adhesion inhibitors |
10/06/1994 | DE4310529A1 Monoclonal antibodies C10 and F1, antibody-producing hybridoma cells and use of the antibodies as markers for a resistance gene |
10/05/1994 | EP0618294A1 Expression of pertussis holotoxin in bordetella pertussis |
10/05/1994 | EP0618293A1 Human contactin, a cell adhesion molecule |
10/05/1994 | EP0618292A1 CEA derivatives lacking the Hydrophobic C-terminal domain |
10/05/1994 | EP0618291A2 PACAP receptor protein, method for preparing said protein, and use thereof |
10/05/1994 | EP0618231A1 Immunologically active conjugates and a method for their preparation |
10/05/1994 | EP0618230A1 Anti-metastatic factor |
10/05/1994 | EP0618229A1 Amylase inhibitors |
10/05/1994 | EP0618227A1 Biologically active polypeptide fusion dimers |
10/05/1994 | EP0618226A1 Inhibitors of herpes viral ribonculeotide reductase |
10/05/1994 | EP0618225A1 Linear adhesion inhibitors |
10/05/1994 | EP0618220A1 Method for purifying interleukin-4 |
10/05/1994 | EP0618219A1 Procedure for obtaining carbocalcitonin |
10/05/1994 | EP0617967A1 Therapeutic reagents based on unique sequences within the variable region of the T cell receptor |
10/05/1994 | EP0617736A1 USE OF $i(BACILLUS THURINGIENSIS) ISOLATES FOR CONTROLLING PESTS IN THE FAMILY APHIDIDAE |
10/05/1994 | EP0617626A1 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation |
10/05/1994 | EP0617614A1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
10/05/1994 | EP0602044A4 A cdna clone encoding a human norepineprhine transporter. |
10/05/1994 | EP0576590A4 Response element compositions and assays employing same |
10/05/1994 | EP0461245A4 Radiolabeled proteins for diagnostic or therapeutic use |
10/05/1994 | EP0232326B1 Inhibin and method of purifying same |
10/05/1994 | CN1093090A Cyclopeptides |
10/04/1994 | US5352815 Agent for suppression and interception of mailard reaction |
10/04/1994 | US5352779 N-linked oligosaccharide chain of glycoprotein coded by DNA molecule eliminated from amino acid position 52 and/or 78 of the alpha subunit |
10/04/1994 | US5352775 Diagnosis, therapy cancer |
10/04/1994 | US5352772 75 Kilodalton interleukin-2 receptor proteins and their uses |
10/04/1994 | US5352770 Porcine derived novel physiologically active peptide |
10/04/1994 | US5352769 Genetic engineering |
10/04/1994 | US5352668 Product and method for improving keratinocyte adhesion to the dermis |
10/04/1994 | US5352664 Thrombin derived polypeptides; compositions and methods for use |
10/04/1994 | US5352662 Injectable extended release formulations and methods |